ARIAD to Present at the Leerink Swann Global Healthcare Conference
February 05 2014 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will present at the Leerink Swann Global Healthcare Conference
being held in New York City. Timothy P. Clackson, Ph.D., president
of research and development and chief scientific officer, will
provide an overview of the Company’s business on Wednesday,
February 12, at 11:05 a.m. (ET).
The ARIAD presentation at the Leerink Swann Global Healthcare
Conference will be webcast live and can be accessed by visiting the
investor relations section of the Company's website at
http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts and Lausanne, Switzerland, is an integrated global
oncology company focused on transforming the lives of cancer
patients with breakthrough medicines. ARIAD is working on new
medicines to advance the treatment of various forms of chronic and
acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer
medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc.For InvestorsKendra Adams,
617-503-7028Kendra.adams@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2023 to Aug 2024